BN Business News
Add your company to Business Communicator →

Regulation & law · 25/07/2025Updated: 10/17/2026 · 1 min read

DEA Extends Temporary Schedule I Status of Five Designer Benzodiazepines

Summary

The Drug Enforcement Administration (DEA) is extending the temporary placement of clonazolam, diclazepam, etizolam, flualprazolam, and flubromazolam in Schedule I of the Controlled Substances Act for one year, or until a permanent scheduling action is completed, whichever occurs first.

Original source language: Federal Register — Justice DepartmentOpen original release →

Explore insights

Business insights →